NCT02685098View on ClinicalTrials.gov

A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 23, 2017

Primary Completion Date

October 3, 2023

Study Completion Date

October 3, 2023

Conditions
IschemiaPeripheral Arterial DiseasePeripheral Vascular DiseaseVascular DiseaseArterial Occlusive DiseaseArteriosclerosisAtherosclerosisCardiovascular DiseasePathologic ProcessesOrthopedic ProceduresAmputation
Interventions
BIOLOGICAL

Allogeneic bone marrow derived mesenchymal stem cells

Injection of HLA-A2+ and/or gender mismatched allogeneic MSCs above the site of amputation and into the anterior tibialis muscle (ATM) of patients scheduled for semi-elective lower extremity major amputation at 7 days before amputation.

Trial Locations (1)

46202

Indiana University, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT02685098 - A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation | Biotech Hunter | Biotech Hunter